(Q35107875)

6 August 2017

1 reference

title

What's new in neuro-oncology? Recent advances in medulloblastoma (English)

1 reference

6 August 2017

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12697428

24 December 2023

4

Richard J. Gilbertson

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12697428

24 December 2023

author name string

Amar Gajjar

3

1 reference

6 August 2017

David W. Ellison

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12697428

24 December 2023

Steven C. Clifford

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12697428

24 December 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12697428

24 December 2023

publication date

1 January 2003

1 reference

full work available at URL

6 August 2017

https://api.elsevier.com/content/article/PII:S109037980300014X?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S1090-3798(03)00014-X

https://api.elsevier.com/content/article/PII:S109037980300014X?httpAccept=text/plain

24 December 2023

1 reference

https://api.crossref.org/works/10.1016/S1090-3798(03)00014-X

European Journal of Paediatric Neurology

24 December 2023

published in

1 reference

6 August 2017

7

1 reference

6 August 2017

53-66

1 reference

6 August 2017

2

1 reference

Comparative genomic hybridization in patients with supratentorial and infratentorial primitive neuroectodermal tumors

6 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3798%2803%2900014-X

7 January 2021

Comparative genomic hybridization and histological variation in primitive neuroectodermal tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3798%2803%2900014-X

7 January 2021

The WHO classification of tumors of the nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3798%2803%2900014-X

7 January 2021

Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3798%2803%2900014-X

7 January 2021

Apoptosis, neuronal maturation, and neurotrophin expression within medulloblastoma nodules.

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3798%2803%2900014-X

7 January 2021

Medulloblastoma with extensive nodularity: a variant with favorable prognosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3798%2803%2900014-X

7 January 2021

Histopathologic grading of medulloblastomas: a Pediatric Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3798%2803%2900014-X

7 January 2021

"Large cell/anaplastic" medulloblastomas: a Pediatric Oncology Group Study.

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3798%2803%2900014-X

7 January 2021

Comparative genomic hybridization detects an increased number of chromosomal alterations in large cell/anaplastic medulloblastomas.

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3798%2803%2900014-X

7 January 2021

Mutations in SUFU predispose to medulloblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3798%2803%2900014-X

7 January 2021

Paediatric embryonic brain tumours. biological and clinical relevance of molecular genetic abnormalities

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3798%2803%2900014-X

7 January 2021

Classifying the medulloblastoma: insights from morphology and molecular genetics

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3798%2803%2900014-X

7 January 2021

Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3798%2803%2900014-X

7 January 2021

The molecular basis of Turcot's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3798%2803%2900014-X

7 January 2021

Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3798%2803%2900014-X

7 January 2021

Medulloblastoma in a child with Rubenstein-Taybi Syndrome: case report and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3798%2803%2900014-X

7 January 2021

Somatic mutations in the human homologue of Drosophila patched in primitive neuroectodermal tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3798%2803%2900014-X

7 January 2021

The Hedgehog and Wnt signalling pathways in cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3798%2803%2900014-X

7 January 2021

Altered neural cell fates and medulloblastoma in mouse patched mutants

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3798%2803%2900014-X

7 January 2021

Analysis of PTCH/SMO/SHH pathway genes in medulloblastoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3798%2803%2900014-X

7 January 2021

APC mutations in sporadic medulloblastomas

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3798%2803%2900014-X

7 January 2021

Somatic mutations of WNT/wingless signaling pathway components in primitive neuroectodermal tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3798%2803%2900014-X

7 January 2021

Nuclear localization and mutation of beta-catenin in medulloblastomas

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3798%2803%2900014-X

7 January 2021

Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: an analysis based on Surveillance, Epidemiology, and End Results (SEER) data, 1973-1991.

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3798%2803%2900014-X

7 January 2021

Medulloblastoma with brain stem involvement: the impact of gross total resection on outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3798%2803%2900014-X

7 January 2021

Growth and endocrine function after chemotherapy and radiotherapy in childhood.

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3798%2803%2900014-X

7 January 2021

Whole-brain irradiation and decline in intelligence: the influence of dose and age on IQ score

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3798%2803%2900014-X

7 January 2021

Results of a prospective randomized trial comparing standard dose neuraxis irradiation (3,600 cGy/20) with reduced neuraxis irradiation (2,340 cGy/13) in patients with low-stage medulloblastoma. A Combined Children's Cancer Group-Pediatric Oncology

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3798%2803%2900014-X

7 January 2021

Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: A Children's Cancer Group Study.

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3798%2803%2900014-X

7 January 2021

Intellectual outcome after reduced-dose radiation therapy plus adjuvant chemotherapy for medulloblastoma: a Children's Cancer Group study

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3798%2803%2900014-X

7 January 2021

Neuropsychologic functioning of survivors of childhood medulloblastoma randomized to receive conventional or reduced-dose craniospinal irradiation: a Pediatric Oncology Group study.

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3798%2803%2900014-X

7 January 2021

Prospective randomised trial of chemotherapy given before radiotherapy in childhood medulloblastoma. International Society of Paediatric Oncology (SIOP) and the (German) Society of Paediatric Oncology (GPO): SIOP II.

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3798%2803%2900014-X

7 January 2021

Results of a randomized study of preradiation chemotherapy versus radiotherapy alone for nonmetastatic medulloblastoma: The International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 Study

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3798%2803%2900014-X

7 January 2021

Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT '91.

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3798%2803%2900014-X

7 January 2021

Medulloblastoma at the joint center for radiation therapy between 1968 and 1984. The influence of radiation dose on the patterns of failure and survival

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3798%2803%2900014-X

7 January 2021

Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3798%2803%2900014-X

7 January 2021

Feasibility of four consecutive high-dose chemotherapy cycles with stem-cell rescue for patients with newly diagnosed medulloblastoma or supratentorial primitive neuroectodermal tumor after craniospinal radiotherapy: results of a collaborative study

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3798%2803%2900014-X

7 January 2021

High-dose chemotherapy with autologous stem-cell rescue in patients with recurrent and high-risk pediatric brain tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3798%2803%2900014-X

7 January 2021

Pilot study of high-dose thiotepa and etoposide with autologous bone marrow rescue in children and young adults with recurrent CNS tumors. The Children's Cancer Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3798%2803%2900014-X

7 January 2021

Myeloablative chemotherapy with autologous bone marrow rescue in young children with recurrent malignant brain tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3798%2803%2900014-X

7 January 2021

High-dose melphalan and cyclophosphamide with autologous bone marrow rescue for recurrent/progressive malignant brain tumors in children: a pilot pediatric oncology group study.

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3798%2803%2900014-X

7 January 2021

Molecular biology of neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3798%2803%2900014-X

7 January 2021

Perspectives on the development of a molecularly targeted agent

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3798%2803%2900014-X

7 January 2021

Expression profiling of medulloblastoma: PDGFRA and the RAS/MAPK pathway as therapeutic targets for metastatic disease

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3798%2803%2900014-X

7 January 2021

Neuropathology of genetically engineered mice: consensus report and recommendations from an international forum

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3798%2803%2900014-X

7 January 2021

Effects of oncogenic mutations in Smoothened and Patched can be reversed by cyclopamine

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3798%2803%2900014-X

7 January 2021

Inhibition of Hedgehog signaling by direct binding of cyclopamine to Smoothened

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3798%2803%2900014-X

7 January 2021

Clinical and molecular stratification of disease risk in medulloblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3798%2803%2900014-X

7 January 2021

Correlation of loss of heterozygosity at chromosome 9q with histological subtype in medulloblastomas

14

1 reference

https://api.crossref.org/works/10.1016/S1090-3798(03)00014-X

Missense mutations in SMOH in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system

24 December 2023

30

1 reference

https://api.crossref.org/works/10.1016/S1090-3798(03)00014-X

24 December 2023

Identifiers

1 reference

6 August 2017

1 reference